Updated Jul 16, 2026
Gordon Gary B. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $65K.
Gordon Gary B. is a director at TriSalus Life Sciences, Inc. His specific contributions and background details are not widely documented in public sources, indicating he may not be a widely recognized figure outside of his role.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 10.0K | $2.46 | $25K |
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 24.6K | $0.00 | |
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 28.2K | $0.00 | |
| 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 9.8K | $4.10 | $40K |
Gordon Gary B. is a director at TriSalus Life Sciences, Inc. His specific contributions and background details are not widely documented in public sources, indicating he may not be a widely recognized figure outside of his role.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($65K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gordon Gary B. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.